Cited by 90Antimicrobial Peptides and ActivitiesAntimicrobial agents and applicationsChemical Synthesis and Analysis

Discovery and development of a synthetic peptide derived from lactoferrin for clinical use

Brouwer, Carlo P.J.M., Rahman, Mahfuzur, Welling, Mick M.·2011·Peptides

Abstract

There is an urgent need to develop new antimicrobial drugs especially for combating the rise of infections caused by multi-resistant pathogens such as MRSA and VRSA. The problem of antibiotic resistant micro-organisms is expected to increase disproportionally and controlling of infections is becoming difficult because of the rapid spread of those micro-organisms. Primary therapy with classical antibiotics is becoming more ineffective. Combinational therapy of antibiotics with antimicrobial peptides (AMP's) has been suggested as an alternative approach to improve treatment outcome. Their unique mechanism of action and safety profile makes AMP's appealing candidates for simultaneous or sequential use in different cases of infections. In this review, for antimicrobial treatment the application of synthetic antimicrobial peptide hLF(1-11), derived from the first 11 amino acids of human lactoferrin is evaluated in both pre-clinical and clinical settings. Present information indicates that this derivate from lactoferrin is well tolerated in pre-clinical tests and clinical trials and thus hLF(1-11) is an interesting candidate for further exploration in various clinical indications of obscure infections, including meningitis. Another approach of using AMP's is their use in prevention of infections e.g. as coating for dental or bone implants or in biosensing applications or useful as infection specific radiopharmaceutical.

Integrity signals

Registry

Crossref · 10.1016/j.peptides.2011.07.017

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 146 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Brouwer, C. P. J. M., Rahman, M., & Welling, M. M.
Affiliations
  • Leiden University Medical Center (NL)
  • NAEJA-RGM Pharmaceuticals (Canada) (CA)
Corresponding author
Brouwer, Carlo P.J.M.
Venue
Peptides
Publisher
Elsevier BV
Published
2011-09
Volume
32
Issue
9
Pages
1953-1963
ISSN
0196-9781 (ISSN-L)
OpenAlex
W2010946839
Cited by
90
References
146
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 11 · 2019: 3 · 2018: 2 · 2017: 9 · 2016: 8 · 2015: 11 · 2014: 11 · 2013: 10 · 2012: 6
FWCI
1.00
Type
journal article
Language
en
Open access
closed
Locations
  • Peptides (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Physical Sciences › Chemistry › Organic Chemistry › Antimicrobial agents and applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chemical Synthesis and Analysis
Keywords
antimicrobial peptides, lactoferrin, synthetic peptides, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Staphylococcus aureus, combination antibiotic therapy, meningitis, implant infection prevention, biosensing, radiopharmaceuticals, clinical trials
MeSH terms
Amino Acid Sequence, Animals, Anti-Infective Agents, Bacterial Infections, Candida, Clinical Trials as Topic, Drug Evaluation, Drug Resistance, Microbial, Drug Synergism, Humans, Lactoferrin, Molecular Sequence Data, Mycoses, Peptide Fragments, Antimicrobial Cationic Peptides, Mice, Methicillin-Resistant Staphylococcus aureus, Drug Discovery, Chemistry Techniques, Synthetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review